Publication | Open Access

A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata

Uterine LeiomyomataHormonal ContraceptiveUterine FibroidsFertilityMedicineHormonal ReceptorReproductive HealthGynecologyReproductive HormoneMenstrual CyclePublic HealthEndocrinologyPharmacologyWomen's Health